Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The NIMH-MATRICS consensus statement on negative symptoms.

Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR.

Schizophr Bull. 2006 Apr;32(2):214-9. Epub 2006 Feb 15. No abstract available.

2.

An industry perspective on the NIMH consensus statement on negative symptoms.

Alphs L.

Schizophr Bull. 2006 Apr;32(2):225-30. Epub 2006 Feb 9.

3.
4.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR.

Biol Psychiatry. 2004 Sep 1;56(5):301-7. Review.

PMID:
15336511
5.

[Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery].

Rodríguez-Jiménez R, Bagney A, Moreno-Ortega M, García-Navarro C, Aparicio AI, López-Antón R, de la Oliva J, Jiménez-Arriero MÁ, Santos JL, Lobo A, Palomo T.

Rev Neurol. 2012 Nov 1;55(9):549-55. Review. Spanish.

6.

Stimulating the development of drug treatments to improve cognition in schizophrenia.

Green MF.

Annu Rev Clin Psychol. 2007;3:159-80. Review.

PMID:
17716052
7.

Reducing dosage in maintenance treatment of schizophrenia. Review and prognosis.

Schooler NR.

Br J Psychiatry Suppl. 1993 Dec;(22):58-65. Review.

PMID:
7906525
8.

[Incidence of the deficit form in refractory schizophrenia].

Samuelian JC.

Encephale. 1996 Jun;22 Spec No 2:19-23. Review. French.

PMID:
8767037
9.

Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities.

Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R.

Schizophr Bull. 2008 Nov;34(6):1211-20. doi: 10.1093/schbul/sbm145. Epub 2008 Jan 8.

10.

[Clozapine and treatment of negative symptoms].

Lançon C, Farisse J, Llorca PM.

Encephale. 1997 Sep;23 Spec No 4:7-11. Review. French.

PMID:
9417403
11.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265
12.

Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report.

Kane JM, Dauphinais D, Barnes TR, Adler LA, Rifkin A.

Psychopharmacol Bull. 1993;29(1):45-9. Review. No abstract available.

PMID:
8104351
13.

Do negative symptoms respond to pharmacological treatment?

Kane JM, Mayerhoff D.

Br J Psychiatry Suppl. 1989 Nov;(7):115-8. Review. No abstract available.

PMID:
2575914
14.

Schizophrenia treatment guidelines in the United States.

Moore TA.

Clin Schizophr Relat Psychoses. 2011 Apr;5(1):40-9. doi: 10.3371/CSRP.5.1.6. Review.

PMID:
21459738
15.

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.

Leucht S, Davis JM, Engel RR, Kissling W, Kane JM.

Acta Psychiatr Scand Suppl. 2009;(438):7-14. doi: 10.1111/j.1600-0447.2008.01308.x. Review. Erratum in: Acta Psychiatr Scand Suppl. 2011 Jul;124(1):82.

PMID:
19132961
16.

Novel antipsychotics and negative symptoms.

Möller HJ.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S43-7. Review.

PMID:
9690970
17.

Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: a review.

Sevy S, Visweswaraiah H, Mentschel C, Leucht S, Schooler NR.

J Clin Psychiatry. 2004 Jun;65(6):756-65. Review.

PMID:
15291652
18.

[Schizophrenic with obsessive-compulsive disorder or symptoms].

Doubremelle C, Millet B, Olie JP.

Encephale. 2000 Mar-Apr;26(2):81-8. Review. French.

PMID:
10858921
19.

The effects of clozapine on cognitive functioning in schizophrenia.

McGurk SR.

J Clin Psychiatry. 1999;60 Suppl 12:24-9. Review.

20.

Heterogeneity of treatment effects in schizophrenia.

Stroup TS.

Am J Med. 2007 Apr;120(4 Suppl 1):S26-31. Review.

PMID:
17403379

Supplemental Content

Support Center